Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation

Zhe Ye; Qiuyan Lin; Hualong Lin; Yiwei Huang

doi:10.22514/ejgo.2026.051

Article Menu

Export Article

Article Data

Views 203
Dowloads 133

This is a correction to: European Journal of Gynaecological Oncology. 2024; 45(2): 147-157. https://doi.org/10.22514/ejgo.2024.037

Corrections

Open Access

Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation

Zhe Ye¹
Qiuyan Lin²
Hualong Lin²
Yiwei Huang^1,*,

¹Department of Tumor Radiotherapy, The Third Affiliated Hospital of Wenzhou Medical University, 325200 Rui’an, Zhejiang, China

²Department of Oncology, The Third Affiliated Hospital of Wenzhou Medical University, 325200 Rui’an, Zhejiang, China

DOI: 10.22514/ejgo.2026.051 Vol.47,Issue 3,October 2026 pp.154-154

Published: 15 October 2026

*Corresponding Author(s): Yiwei Huang E-mail: yw_huang0711@163.com

PDF (224.21 kB) View Full-text

Cite and Share

Zhe Ye, Qiuyan Lin, Hualong Lin, Yiwei Huang. Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation. European Journal of Gynaecological Oncology. 2026; 47(3): 154-154. doi: 10.22514/ejgo.2026.051

URL:

https://www.ejgo.net/articles/10.22514/ejgo.2026.051

References

[1] Ye Z, Lin QY, Lin HL, Huang YW. Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation. European Journal of Gynaecological Oncology. 2024; 45: 147–157.